Business● Low20m ago · Nov 13, 2026, 2:30 AM
NeuroPace expects ~15% RNS growth in 2027 as it revises 2026 revenue guidance to $91M-$92M
GlobeAlert Desk · curated from Seeking Alpha Tech · global
NeuroPace projects approximately 15% growth for its RNS product in 2027 and has updated its revenue forecast for 2026 to between $91 million and $92 million. This provides an update on the company's financial outlook and product performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business15m agoLiberty’s $80 million Brooklyn practice facility won’t be ready for training campNY Post · United StatesBusiness20m agoJapan approves energy subsidies of 3.675 billion euros due to Middle East crisisInfobae · ArgentinaBusiness20m agoCibus targets biofragrance peak revenue up to $100M while aiming for rice launch as early as 2028Seeking Alpha TechBusiness31m agoCytosorbents outlines early 2027 DrugSorb-ATR De Novo plan with $300M initial U.S./Canada marketSeeking Alpha Tech